{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:52:04Z","timestamp":1784361124681,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10549-016-3893-x","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T19:24:13Z","timestamp":1467746653000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer"],"prefix":"10.1007","volume":"158","author":[{"given":"M. A.","family":"Aleskandarany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Ashankyty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Elmouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Diez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"issue":"1","key":"3893_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-007-0435-2","volume":"451","author":"D Park","year":"2007","unstructured":"Park D, Karesen R, Noren T, Sauer T (2007) Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications. Virchows Arch 451(1):11\u201318","journal-title":"Virchows Arch"},{"key":"3893_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2559.2002.01343.x","volume":"40","author":"DC Brown","year":"2002","unstructured":"Brown DC, Gatter KC (2002) Ki67 protein: the immaculate deception? Histopathology 40:2\u201311","journal-title":"Histopathology"},{"issue":"7","key":"3893_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2184.1996.tb00984.x","volume":"29","author":"HJ Heidebrecht","year":"1996","unstructured":"Heidebrecht HJ, Buck F, Haas K, Wacker HH, Parwaresch R (1996) Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the \u2018Ki-67\u2032 proteins. Cell Prolif 29(7):413\u2013425","journal-title":"Cell Prolif"},{"issue":"4","key":"3893_CR4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/(SICI)1097-4644(20000315)76:4<596::AID-JCB8>3.0.CO;2-N","volume":"76","author":"YL Wu","year":"2000","unstructured":"Wu YL, Luo HY, Kanaan N, Wu JP (2000) The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67. J Cell Biochem 76(4):596\u2013604","journal-title":"J Cell Biochem"},{"key":"3893_CR5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/annonc\/mdi352","volume":"16","author":"M Colozza","year":"2005","unstructured":"Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ (2005) Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 16:1723\u20131739","journal-title":"Ann Oncol"},{"issue":"11","key":"3893_CR6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0046-8177(99)90062-X","volume":"30","author":"HA Lehr","year":"1999","unstructured":"Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, Trouet S, Gown AM (1999) Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol 30(11):1314\u20131320","journal-title":"Hum Pathol"},{"issue":"2","key":"3893_CR7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1200\/JCO.1999.17.2.470","volume":"17","author":"AD Thor","year":"1999","unstructured":"Thor AD, Liu S, Moore DH 2nd, Edgerton SM (1999) Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17(2):470\u2013477","journal-title":"J Clin Oncol"},{"issue":"5","key":"3893_CR8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.11188","volume":"97","author":"H Trihia","year":"2003","unstructured":"Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, Coates AS, Collins J, Castiglione-Gertsch M, Gusterson BA (2003) Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors\u2013a surrogate marker? Cancer 97(5):1321\u20131331","journal-title":"Cancer"},{"issue":"1","key":"3893_CR9","first-page":"147","volume":"2","author":"W Domagala","year":"1996","unstructured":"Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M (1996) Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res 2(1):147\u2013154","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3893_CR10","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.bjc.6603756","volume":"96","author":"E Azambuja de","year":"2007","unstructured":"de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96(10):1504\u20131513","journal-title":"Br J Cancer"},{"issue":"34","key":"3893_CR11","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1200\/JCO.2008.17.0829","volume":"26","author":"G Viale","year":"2008","unstructured":"Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell\u2019Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C et al (2008) Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol 26(34):5569\u20135575","journal-title":"J Clin Oncol"},{"issue":"7","key":"3893_CR12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/ijc.24860","volume":"126","author":"MA Aleskandarany","year":"2010","unstructured":"Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, Paish EC, Macmillan RD, Chan S, Ahmed SI et al (2010) Growth fraction as a predictor of response to chemotherapy in node negative breast cancer. Int J Cancer 126(7):1761\u20131769","journal-title":"Int J Cancer"},{"issue":"1","key":"3893_CR13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/labinvest.2013.128","volume":"94","author":"JR Brown","year":"2014","unstructured":"Brown JR, DiGiovanna MP, Killelea B, Lannin DR, Rimm DL (2014) Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer. Lab Invest 94(1):98\u2013106","journal-title":"Lab Invest"},{"key":"3893_CR14","first-page":"628217","volume":"2014","author":"J-B Ingolf","year":"2014","unstructured":"Ingolf J-B, Russalina M, Simona M, Julia R, Gilda S, Bohle RM, Andrea H, Erich S, Daniel H (2014) Can Ki-67 play a role in prediction of breast cancer patients\u2019 response to neoadjuvant chemotherapy? BioMed Res Int 2014:628217","journal-title":"BioMed Res Int"},{"issue":"2","key":"3893_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12282-010-0239-0","volume":"18","author":"H Takei","year":"2011","unstructured":"Takei H, Kurosumi M, Yoshida T, Hayashi Y, Higuchi T, Uchida S, Ninomiya J, Oba H, Inoue K, Nagai S et al (2011) Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages? Breast cancer 18(2):85\u201391","journal-title":"Breast cancer"},{"issue":"16","key":"3893_CR16","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-12-3628","volume":"19","author":"G Minckwitz von","year":"2013","unstructured":"von Minckwitz G, Schmitt WD, Loibl S, Muller BM, Blohmer JU, Sinn BV, Eidtmann H, Eiermann W, Gerber B, Tesch H et al (2013) Ki67 measured after neoadjuvant chemotherapy for primary breast cancer. Clin Cancer Res 19(16):4521\u20134531","journal-title":"Clin Cancer Res"},{"key":"3893_CR17","doi-asserted-by":"crossref","unstructured":"Untch M, Gerber B, Harbeck N, Jackisch C, Marschner N, Mobus V, von Minckwitz G, Loibl S, Beckmann MW, Blohmer JU et al (2013) 13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus-opinion of a german team of experts (zurich 2013) (1661\u20133791)","DOI":"10.1159\/000351692"},{"issue":"Suppl 5","key":"3893_CR18","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, Zackrisson S, Cardoso F, Committee EG (2015) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v8\u201330","journal-title":"Ann Oncol"},{"issue":"27","key":"3893_CR19","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817\u20132826","journal-title":"N Engl J Med"},{"issue":"Suppl 24","key":"3893_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/0008-5472.SABCS-09-74","volume":"69","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Dowsett M, Wale C, Salter J, Quinn E, Zabaglo L, Howell A, Buzdar A, Forbes JF (2009) Prognostic value of a combined ER, PgR, Ki67, HER2 immunohistochemical (IHC4) score and comparison with the GHI recurrence score\u2013results from TransATAC. Cancer Res 69(Suppl 24):74","journal-title":"Cancer Res"},{"issue":"32","key":"3893_CR21","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","volume":"29","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO et al (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer. J Clin Oncol 29(32):4273\u20134278","journal-title":"J Clin Oncol"},{"issue":"3","key":"3893_CR22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-010-1028-3","volume":"127","author":"MA Aleskandarany","year":"2011","unstructured":"Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR (2011) MIB1\/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. Breast Cancer Res Treat 127(3):591\u2013599","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3893_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.breast.2014.02.003","volume":"23","author":"G Cserni","year":"2014","unstructured":"Cserni G, V\u00f6r\u00f6s A, Liepniece-Karele I, Bianchi S, Vezzosi V, Grabau D, Sapino A, Castellano I, Regitnig P, Foschini MP et al (2014) Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values. The Breast 23(3):259\u2013263","journal-title":"The Breast"},{"key":"3893_CR24","doi-asserted-by":"crossref","unstructured":"Dowsett M, Nielsen To, A\u2019Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L et al (2011) Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group (1460\u20132105 (Electronic))","DOI":"10.1093\/jnci\/djr393"},{"key":"3893_CR25","doi-asserted-by":"crossref","unstructured":"Polley MY, Leung Sc, McShane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JMS, Gown AM et al (2013) An international Ki67 reproducibility study (1460\u20132105 (Electronic))","DOI":"10.1093\/jnci\/djt306"},{"issue":"10","key":"3893_CR26","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","volume":"28","author":"KD Voduc","year":"2010","unstructured":"Voduc KD, Cheang MCU, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28(10):1684\u20131691","journal-title":"J Clin Oncol"},{"key":"3893_CR27","doi-asserted-by":"crossref","unstructured":"Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JFR, Macmillan D, Blamey RW, Ellis IO (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses (0020\u20137136)","DOI":"10.1002\/ijc.21004"},{"issue":"7","key":"3893_CR28","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","volume":"15","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA et al (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302\u20132310","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3893_CR29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2559.2007.02638.x","volume":"50","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Paish EC, Lee AH, Ellis IO (2007) Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology 50(4):434\u2013438","journal-title":"Histopathology"},{"issue":"15","key":"3893_CR30","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/cncr.26711","volume":"118","author":"EA Rakha","year":"2012","unstructured":"Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, Macmillan D, Ellis IO (2012) The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer 118(15):3670\u20133680","journal-title":"Cancer"},{"issue":"2","key":"3893_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA (2010) Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 11(2):174\u2013183","journal-title":"Lancet Oncol"},{"issue":"1","key":"3893_CR32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910310104","volume":"31","author":"J Gerdes","year":"1983","unstructured":"Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal-antibody reactive with a human nuclear antigen associated with cell-proliferation. Int J Cancer 31(1):13\u201320","journal-title":"Int J Cancer"},{"issue":"1","key":"3893_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1091\/mbc.E10-04-0335","volume":"23","author":"TJ Mitchison","year":"2012","unstructured":"Mitchison TJ (2012) The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell 23(1):1\u20136","journal-title":"Mol Biol Cell"},{"issue":"10","key":"3893_CR34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101(10):736\u2013750","journal-title":"J Natl Cancer Inst"},{"key":"3893_CR35","doi-asserted-by":"crossref","unstructured":"Abubakar M, Howat WJ, Daley F, Zabaglo L, McDuffus L-A, Blows F, Coulson P, Raza Ali H, Benitez J, Milne R et al (2016) High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium. J Pathol","DOI":"10.1002\/cjp2.42"},{"issue":"4","key":"3893_CR36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/modpathol.2013.153","volume":"27","author":"LP Feeley","year":"2014","unstructured":"Feeley LP, Mulligan AM, Pinnaduwage D, Bull SB, Andrulis IL (2014) Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. Mod Pathol 27(4):554\u2013561","journal-title":"Mod Pathol"},{"issue":"3","key":"3893_CR37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00428-006-0233-2","volume":"449","author":"A Sapino","year":"2006","unstructured":"Sapino A, Marchio C, Senetta R, Castellano I, Macri L, Cassoni P, Ghisolfi G, Cerrato M, D\u2019Ambrosio E, Bussolati G (2006) Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch 449(3):288\u2013296","journal-title":"Virchows Arch"},{"key":"3893_CR38","doi-asserted-by":"crossref","unstructured":"Knutsvik G, Stefansson IM, Aziz S, Arnes J, Eide J, Collett K, Akslen LA (2014) Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays (1932\u20136203 (Electronic))","DOI":"10.1371\/journal.pone.0112121"},{"issue":"2","key":"3893_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jamcollsurg.2012.09.007","volume":"216","author":"LT Greer","year":"2013","unstructured":"Greer LT, Rosman M, Mylander WC, Hooke J, Kovatich A, Sawyer K, Buras RR, Shriver CD, Tafra L (2013) Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens? J Am Coll Surg 216(2):239\u2013251","journal-title":"J Am Coll Surg"},{"issue":"4","key":"3893_CR40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.anndiagpath.2015.05.002","volume":"19","author":"K Mu","year":"2015","unstructured":"Mu K, Li L, Yang Q, Yun H, Kharaziha P, Ye DW, Auer G, Lagercrantz SB, Zetterberg A (2015) A standardized method for quantifying proliferation by Ki-67 and cyclin a immunohistochemistry in breast cancer. Ann Diagn Pathol 19(4):243\u2013248","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"3893_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2101","volume":"8","author":"DX Nguyen","year":"2007","unstructured":"Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8(5):341\u2013352","journal-title":"Nat Rev Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3893-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3893-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T03:39:17Z","timestamp":1718681957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3893-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3893"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3893-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}